Future Fields is pioneering the next generation of biomanufacturing—using nature’s most efficient bioreactor to lead the way in complex protein expression. At the core of our work is the EntoEngine®, our proprietary platform that leverages whole, genetically engineered fruit flies (Drosophila melanogaster). By embracing the simple elegance of a model organism backed by over a century of research, we bypass the heavy infrastructure and high costs of traditional cell culture. The result is a flexible, highly scalable platform engineered to express complex recombinant proteins that traditional systems struggle to produce. To meet global demand, we built Instar 1.0 next door to our HQ in Edmonton, Canada. Outfitted with ISO Class 7 and 8 cleanrooms, this first-of-its-kind facility translates our technology into reliable, high-capacity production. We partner closely with clients across life sciences, agriculture, and food innovation to deliver quality-assured biomolecules that advance breakthrough science. We care deeply about our people, our partners, and the planet. As a My Green Lab Green-certified lab, a 1% for the Planet business member, and a participant in the UN Global Compact, we hold ourselves to rigorous environmental and professional standards. Powered by people and fly by design, we bring care, quality, and proven science to everything we build. Explore our platform, services, and vision at futurefields.io.
Looking for a particular Future Fields employee's phone or email?
The Future Fields annual revenue was $6.3 million in 2026.
Matt Anderson-Baron is the CEO of Future Fields.
30 people are employed at Future Fields.
Future Fields is based in Edmonton, Alberta.
The NAICS codes for Future Fields are [51, 51731, 54, 541, 517312, 517, 5173].
The SIC codes for Future Fields are [481, 48, 737, 73].